Johnson & Johnson (J&J) has announced that its dual-acting IL-23 inhibitor Tremfya (guselkumab) has been approved by the European Commission (EC) to treat adults with ulcerative colitis (UC).

MATILDA Ahdrian had her rectum removed and her anus sewn shut to save her life – a major operation that’s been dubbed ‘Barbie Butt’. “I don’t have a bum hole anymore ...

Biosimilars are proving to be a game-changing solution in the fight against inflammatory bowel disease (IBD), offering a cost ...

Autoimmune diseases are known for being critical to handle and treat, but today, with the advancements in modern medicines ...

Explore the complexities of Ulcerative Colitis, its causes, diagnostic methods, and breakthrough treatments for better ...

A breakdown of Crohn’s disease, its symptoms, causes, and long-term impact on health. Explore the causes, symptoms, diagnosis ...